Early immune pressure initiated by tissue-resident memory T cells sculpts tumor evolution in non-small cell lung cancer
antigen presentation; cancer immunosurveillance; cigarette smoking; immune evasion; immunotherapy; lung cancer; tissue-resident memory T cells; tumor evolution.- Cancer Cell
- 38.585
- 2023 May 8;41(5):837-852.e6.
- 流式
- 呼吸系统
- T细胞
- 肺癌
- CD140b,CD27,CD335 (NKp46),CD45.2,Ki-67,
相关货号
LXFM12-2
Abstract
Tissue-resident memory T (TRM) cells provide immune defense against local infection and can inhibit cancer progression. However, it is unclear to what extent chronic inflammation impacts TRM activation and whether TRM cells existing in tissues before tumor onset influence cancer evolution in humans. We performed deep profiling of healthy lungs and lung cancers in never-smokers (NSs) and ever-smokers (ESs), finding evidence of enhanced immunosurveillance by cells with a TRM-like phenotype in ES lungs. In preclinical models, tumor-specific or bystander TRM-like cells present prior to tumor onset boosted immune cell recruitment, causing tumor immune evasion through loss of MHC class I protein expression and resistance to immune checkpoint inhibitors. In humans, only tumors arising in ES patients underwent clonal immune evasion, unrelated to tobacco-associated mutagenic signatures or oncogenic drivers. These data demonstrate that enhanced TRM-like activity prior to tumor development shapes the evolution of tumor immunogenicity and can impact immunotherapy outcomes. Keywords: antigen presentation; cancer immunosurveillance; cigarette smoking; immune evasion; immunotherapy; lung cancer; tissue-resident memory T cells; tumor evolution.
金课堂之文献解析 文献原文请点击
本网站销售的所有产品及服务均不得用于人类或动物之临床诊断或治疗,仅可用于工业或者科研等非医疗目的。